Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental isoniazid poisoning |
Causative agent (attribute) |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Intentional isoniazid poisoning |
Causative agent (attribute) |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
intoxication par l'isoniazide d'intention indéterminée |
Causative agent (attribute) |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid adverse reaction (disorder) |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid overdose |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Accidental isoniazid overdose |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Intentional isoniazid overdose |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
surdose d'isoniazide d'intention indéterminée |
Causative agent (attribute) |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 50mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 25mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 50mg/5mL oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 100mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Poisoning by isoniazid |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isonicotinic acid hydrazide measurement |
Component |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing isoniazid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Product containing isoniazid and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing isoniazid and pyrazinamide and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid 100mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Urine isoniazid measurement (procedure) |
Component |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Ethambutol hydrochloride+isoniazid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Accidental isoniazid poisoning |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Intentional isoniazid poisoning |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Allergy to isoniazid |
Causative agent (attribute) |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid +rifampin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
|
Isoniazid-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Allergy to isoniazid |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Neuropathy caused by isoniazid |
Causative agent (attribute) |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing isoniazid and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing ethambutol and isoniazid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Ethambutol- and isoniazid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing ethambutol and isoniazid and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Ethambutol- and isoniazid- and rifampicin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Isoniazid 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Isoniazid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Isoniazid 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Isoniazid 10 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid 10 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 50 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 50 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Ethambutol and isoniazid and rifampicin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Ethambutol and isoniazid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Product containing only isoniazid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Isoniazid and pyrazinamide and rifampicin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Isoniazid and rifampicin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Product containing only ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing only ethambutol and isoniazid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing only isoniazid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing only isoniazid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
1 |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
4 |
Isoniazid 75 mg and rifampicin 150 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isoniazid (substance) |
Inferred relationship |
Some |
2 |